Description: Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.
Home Page: www.supriyalifescience.com
207/208 Udyog Bhavan
Mumbai,
400063
India
Phone:
91 22 4033 2727
Officers
| Name | Title |
|---|---|
| Dr. Satish Waman Wagh | Founder, Executive Chairman & Whole Time Director |
| Ms. Smita Satish Wagh | Whole-time Director |
| Dr. Saloni Satish Wagh | Managing Director |
| Ms. Shivani Satish Wagh | Joint Managing Director |
| Mr. Balasaheb Gulabrao Sawant | Whole Time Director |
| Mr. Krishna Raghunathan | Chief Financial Officer |
| Dr. Shireesh Bhalchandra Ambhaikar | Technical Head |
| Dr. Sushanta Kumar Gouranga Mishra | Chief Scientific Officer |
| Ms. Shweta Shivdhari Singh | Compliance Officer & Company Secretary |
| Dr. Prashant Baban Zate | Head of Corporate Quality Assurance & Regulatory Affairs |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 39.6872 |
| Price-to-Book MRQ: | 6.8756 |
| Price-to-Sales TTM: | 10.0736 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 448 |